Report Detail
(Post-pandemic Era)-Global Pharmacokinetics Services Market Segment Research Report 2022
- RnM4477213 |
- 04 August, 2022 |
- Global |
- 116 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Pharmacokinetics Services Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Pharmacokinetics Services industry at home and abroad, estimate the overall market scale of the Pharmacokinetics Services industry and the market share of major countries, Pharmacokinetics Services industry, and study and judge the downstream market demand of Pharmacokinetics Services through systematic research, Analyze the competition pattern of Pharmacokinetics Services, so as to help solve the pain points of various stakeholders in Pharmacokinetics Services industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Pharmacokinetics Services Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Pharmacokinetics Services Market?
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
Major Type of Pharmacokinetics Services Covered in XYZResearch report:
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Application Segments Covered in XYZResearch Market
Small & Medium Enterprise
Large Enterprise
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Pharmacokinetics Services Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Pharmacokinetics Services Market by Value
- 2.2.1 Global Pharmacokinetics Services Revenue by Type
- 2.2.2 Global Pharmacokinetics Services Market by Value (%)
- 2.3 Global Pharmacokinetics Services Market by Production
- 2.3.1 Global Pharmacokinetics Services Production by Type
- 2.3.2 Global Pharmacokinetics Services Market by Production (%)
3. The Major Driver of Pharmacokinetics Services Industry
- 3.1 Historical & Forecast Global Pharmacokinetics Services Demand
- 3.2 Largest Application for Pharmacokinetics Services (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Pharmacokinetics Services Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Pharmacokinetics Services Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Pharmacokinetics Services Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Pharmacokinetics Services Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Pharmacokinetics Services Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Pharmacokinetics Services Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Pharmacokinetics Services Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Pharmacokinetics Services Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Pharmacokinetics Services Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Pharmacokinetics Services Average Price Trend
- 12.1 Market Price for Each Type of Pharmacokinetics Services in US (2018-2022)
- 12.2 Market Price for Each Type of Pharmacokinetics Services in Europe (2018-2022)
- 12.3 Market Price for Each Type of Pharmacokinetics Services in China (2018-2022)
- 12.4 Market Price for Each Type of Pharmacokinetics Services in Japan (2018-2022)
- 12.5 Market Price for Each Type of Pharmacokinetics Services in India (2018-2022)
- 12.6 Market Price for Each Type of Pharmacokinetics Services in Korea (2018-2022)
- 12.7 Market Price for Each Type of Pharmacokinetics Services in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Pharmacokinetics Services Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Pharmacokinetics Services
14. Pharmacokinetics Services Competitive Landscape
- 14.1 Evotec AG (Germany)
- 14.1.1 Evotec AG (Germany) Company Profiles
- 14.1.2 Evotec AG (Germany) Product Introduction
- 14.1.3 Evotec AG (Germany) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 Pacific BioLabs (US)
- 14.2.1 Pacific BioLabs (US) Company Profiles
- 14.2.2 Pacific BioLabs (US) Product Introduction
- 14.2.3 Pacific BioLabs (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 GVK Biosciences Private Limited (India)
- 14.3.1 GVK Biosciences Private Limited (India) Company Profiles
- 14.3.2 GVK Biosciences Private Limited (India) Product Introduction
- 14.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 Shanghai Medicilon Inc. (China)
- 14.4.1 Shanghai Medicilon Inc. (China) Company Profiles
- 14.4.2 Shanghai Medicilon Inc. (China) Product Introduction
- 14.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 Pharmaceutical Product Development, LLC (US)
- 14.5.1 Pharmaceutical Product Development, LLC (US) Company Profiles
- 14.5.2 Pharmaceutical Product Development, LLC (US) Product Introduction
- 14.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Charles River Laboratories International, Inc. (US)
- 14.6.1 Charles River Laboratories International, Inc. (US) Company Profiles
- 14.6.2 Charles River Laboratories International, Inc. (US) Product Introduction
- 14.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 PAREXEL International Corporation (US)
- 14.7.1 PAREXEL International Corporation (US) Company Profiles
- 14.7.2 PAREXEL International Corporation (US) Product Introduction
- 14.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Eurofins Scientific, Inc. (Luxembourg)
- 14.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Profiles
- 14.8.2 Eurofins Scientific, Inc. (Luxembourg) Product Introduction
- 14.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 Frontage Labs (US)
- 14.9.1 Frontage Labs (US) Company Profiles
- 14.9.2 Frontage Labs (US) Product Introduction
- 14.9.3 Frontage Labs (US) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
- 14.10 SGS SA (Switzerland)
- 14.10.1 SGS SA (Switzerland) Company Profiles
- 14.10.2 SGS SA (Switzerland) Product Introduction
- 14.10.3 SGS SA (Switzerland) Pharmacokinetics Services Sales, Revenue (2018-2022)
- 14.10.4 Strategic initiatives
- 14.11 LGC Limited (UK)
- 14.12 Creative Bioarray (US)
- 14.13 Certara, L.P. (Germany)
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Pharmacokinetics Services. Industry analysis & Market Report on Pharmacokinetics Services is a syndicated market report, published as (Post-pandemic Era)-Global Pharmacokinetics Services Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Pharmacokinetics Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
